NO20040043L - Granulater inneholdende fettoppløselige forbindelser og en fremgangsmåte for fremstillingen derav - Google Patents

Granulater inneholdende fettoppløselige forbindelser og en fremgangsmåte for fremstillingen derav

Info

Publication number
NO20040043L
NO20040043L NO20040043A NO20040043A NO20040043L NO 20040043 L NO20040043 L NO 20040043L NO 20040043 A NO20040043 A NO 20040043A NO 20040043 A NO20040043 A NO 20040043A NO 20040043 L NO20040043 L NO 20040043L
Authority
NO
Norway
Prior art keywords
preparation
water
soluble compounds
granules containing
containing fat
Prior art date
Application number
NO20040043A
Other languages
English (en)
Inventor
Alberto Reiner
Original Assignee
Fidia Farm Spa
Apr Applied Pharma Res Sa
Ipsen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa, Apr Applied Pharma Res Sa, Ipsen Spa filed Critical Fidia Farm Spa
Publication of NO20040043L publication Critical patent/NO20040043L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040043A 2001-07-11 2004-01-06 Granulater inneholdende fettoppløselige forbindelser og en fremgangsmåte for fremstillingen derav NO20040043L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202657A EP1275377B1 (en) 2001-07-11 2001-07-11 Granulates containing liposoluble substances and process of preparation thereof
PCT/EP2002/007636 WO2003005989A2 (en) 2001-07-11 2002-07-09 Granulates containing liposoluble substances and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
NO20040043L true NO20040043L (no) 2004-01-06

Family

ID=8180628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040043A NO20040043L (no) 2001-07-11 2004-01-06 Granulater inneholdende fettoppløselige forbindelser og en fremgangsmåte for fremstillingen derav

Country Status (21)

Country Link
US (1) US7615547B2 (no)
EP (1) EP1275377B1 (no)
JP (1) JP2004536118A (no)
KR (1) KR100877628B1 (no)
AT (1) ATE243028T1 (no)
AU (1) AU2002328866B2 (no)
BR (1) BR0211081A (no)
CA (1) CA2452386C (no)
DE (1) DE60100389T2 (no)
DK (1) DK1275377T3 (no)
ES (1) ES2199202T3 (no)
HR (1) HRP20040010A2 (no)
IL (1) IL159346A0 (no)
MX (1) MXPA04000211A (no)
NO (1) NO20040043L (no)
NZ (1) NZ530473A (no)
PL (1) PL204963B1 (no)
PT (1) PT1275377E (no)
RU (1) RU2288704C2 (no)
WO (1) WO2003005989A2 (no)
ZA (1) ZA200309680B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080486A1 (en) 2000-11-29 2005-04-14 Fallin T. Wade Facet joint replacement
US6579319B2 (en) 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US6419703B1 (en) 2001-03-01 2002-07-16 T. Wade Fallin Prosthesis for the replacement of a posterior element of a vertebra
US7090698B2 (en) 2001-03-02 2006-08-15 Facet Solutions Method and apparatus for spine joint replacement
US8926700B2 (en) 2003-12-10 2015-01-06 Gmedelware 2 LLC Spinal facet joint implant
US7588578B2 (en) 2004-06-02 2009-09-15 Facet Solutions, Inc Surgical measurement systems and methods
JP2009518395A (ja) * 2005-12-09 2009-05-07 テバ ファーマシューティカル インダストリーズ リミティド 難溶性化合物の水性分散物および溶液ならびにそれらの調製方法
KR100954828B1 (ko) 2006-12-22 2010-04-27 주식회사유한양행 레바프라잔 함유 고체분산체 및 그의 제조방법
EP3702442B1 (en) * 2011-12-22 2025-06-25 Life Technologies Corporation Cell culture media and methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
PL3641726T3 (pl) * 2017-06-23 2026-02-23 Nordiccan A/S Woreczek z kannabinoidami
CN108309933A (zh) * 2018-03-19 2018-07-24 青岛国海生物制药有限公司 一种口服醋酸甲地孕酮纳米混悬液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
JPH0449232A (ja) 1990-06-15 1992-02-18 Fujisawa Pharmaceut Co Ltd 懸濁用組成物または懸濁液並びにそれらの製造法
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
PL177323B1 (pl) 1993-10-01 1999-10-29 Syntex Inc Kompozycja farmaceutyczna zawierająca mykofenolan mofetylu lub kwas mykofenolowy i sposób wytwarzania kompozycji farmaceutycznej zawierającej mykofenolan mofetylu lub kwas mykofenolowy
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
FR2730163B1 (fr) 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
EP0914822A4 (en) 1996-03-14 2002-08-07 Bayer Ag PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form

Also Published As

Publication number Publication date
IL159346A0 (en) 2004-06-01
WO2003005989A3 (en) 2003-05-01
MXPA04000211A (es) 2005-03-07
US7615547B2 (en) 2009-11-10
JP2004536118A (ja) 2004-12-02
PL369294A1 (en) 2005-04-18
RU2004103853A (ru) 2005-03-27
ES2199202T3 (es) 2004-02-16
AU2002328866B2 (en) 2007-02-15
EP1275377B1 (en) 2003-06-18
CA2452386A1 (en) 2003-01-23
DK1275377T3 (da) 2003-10-06
ATE243028T1 (de) 2003-07-15
PL204963B1 (pl) 2010-02-26
DE60100389T2 (de) 2004-05-19
HRP20040010B1 (no) 2007-01-31
BR0211081A (pt) 2004-12-14
ZA200309680B (en) 2004-12-22
US20040009232A1 (en) 2004-01-15
CA2452386C (en) 2011-01-18
KR20040018440A (ko) 2004-03-03
WO2003005989A2 (en) 2003-01-23
RU2288704C2 (ru) 2006-12-10
HRP20040010A2 (en) 2004-06-30
NZ530473A (en) 2006-02-24
DE60100389D1 (de) 2003-07-24
KR100877628B1 (ko) 2009-01-07
EP1275377A1 (en) 2003-01-15
PT1275377E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
DK1275377T3 (da) Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf
PL346714A1 (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
WO2003000014A3 (en) Spherical protein particles and methods of making and using them
WO2003002136A3 (en) Stable formulation of modified glp-1
CA2024291A1 (en) Dosage device and preparation and use thereof
DE69909790D1 (de) Antitrombotische mitteln
DE50110049D1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
EP1483579A4 (en) CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
MY124599A (en) Oral suspension of pharmaceutical substance
DK1368006T3 (da) Hidtil ukendt formulering med modificeret frigivelse
PT1166645E (pt) Amido aglomerado e produto a base de maltodextrina para a preparacao de alimentos
ATE380016T1 (de) Aufstreuverfahren zur herstellung von pulverformulierungen
WO2002056881A8 (fr) Comprimes de fenofibrate
EA200600085A1 (ru) Капсулы флуконазола с улучшенным высвобождением
PT1186292E (pt) Preparados solidos com estrutura multinuclear
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
BR0215134A (pt) Processo para a preparação de grânulos solúveis, isentos de pó, de compactação baixa, quimicamente estáveis de amidotioatos de fósforo
ZA200202402B (en) Sustained-release drug formulations for implantation.
ES2171145A1 (es) Formulacion aceleradora de la descomposicion de materia organica en general y de restos animales en particular; procedimiento para su preparacion y aplicaciones.
WO2002058673A8 (en) Method of preparing pharmaceutical or dietary compositions for conveying labile substances into the intestine
ATE145555T1 (de) Neue pharmazeutische formulierung enthaltend spiramycine
RU2002121504A (ru) Лекарственные средства для лечения дегенеративного артрита